Cargando…

Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis

Background: The effects of diabetes on the cardiovascular system as well as in the kidney are profound, which include hypertrophy and fibrosis. Diabetes also induces oxidative stress, at least in part due to the uncoupling of nitric oxide synthase (NOS); this is a shift in NO production toward super...

Descripción completa

Detalles Bibliográficos
Autores principales: Novoa, Ulises, Soto, Karen, Valdés, Cristian, Villaseñor, Jorge, Treuer, Adriana V., González, Daniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599239/
https://www.ncbi.nlm.nih.gov/pubmed/36289741
http://dx.doi.org/10.3390/biomedicines10102479
_version_ 1784816546976104448
author Novoa, Ulises
Soto, Karen
Valdés, Cristian
Villaseñor, Jorge
Treuer, Adriana V.
González, Daniel R.
author_facet Novoa, Ulises
Soto, Karen
Valdés, Cristian
Villaseñor, Jorge
Treuer, Adriana V.
González, Daniel R.
author_sort Novoa, Ulises
collection PubMed
description Background: The effects of diabetes on the cardiovascular system as well as in the kidney are profound, which include hypertrophy and fibrosis. Diabetes also induces oxidative stress, at least in part due to the uncoupling of nitric oxide synthase (NOS); this is a shift in NO production toward superoxide production due to reduced levels of the NOS cofactor tetrahydrobiopterin (BH(4)). With this in mind, we tested the hypothesis that BH(4) supplementation may prevent the development of diabetic cardiomyopathy and nephropathy. Methods: Diabetes was induced in Balb/c mice with streptozotocin. Then, diabetic mice were divided into two groups: one group provided with BH(4) (sapropterin) in drinking water (daily doses of 15 mg/kg/day, during eight weeks) and the other that received only water. A third group of normoglycemic mice that received only water were used as the control. Results: Cardiac levels of BH(4) were increased in mice treated with BH(4) (p = 0.0019). Diabetes induced cardiac hypertrophy, which was prevented in the group that received BH(4) (p < 0.05). In addition, hypertrophy was evaluated as cardiomyocyte cross-sectional area. This was reduced in diabetic mice that received BH(4) (p = 0.0012). Diabetes induced cardiac interstitial fibrosis that was reduced in mice that received BH(4) treatment (p < 0.05). We also evaluated in the kidney the impact of BH(4) treatment on glomerular morphology. Diabetes induced glomerular hypertrophy compared with normoglycemic mice and was prevented by BH(4) treatment. In addition, diabetic mice presented glomerular fibrosis, which was prevented in mice that received BH(4). Conclusions: These results suggest that chronic treatment with BH(4) in mice ameliorates the cardiorenal effects of diabetes,(,) probably by restoring the nitroso–redox balance. This offers a possible new alternative to explore a BH(4)-based treatment for the organ damage caused by diabetes.
format Online
Article
Text
id pubmed-9599239
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95992392022-10-27 Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis Novoa, Ulises Soto, Karen Valdés, Cristian Villaseñor, Jorge Treuer, Adriana V. González, Daniel R. Biomedicines Article Background: The effects of diabetes on the cardiovascular system as well as in the kidney are profound, which include hypertrophy and fibrosis. Diabetes also induces oxidative stress, at least in part due to the uncoupling of nitric oxide synthase (NOS); this is a shift in NO production toward superoxide production due to reduced levels of the NOS cofactor tetrahydrobiopterin (BH(4)). With this in mind, we tested the hypothesis that BH(4) supplementation may prevent the development of diabetic cardiomyopathy and nephropathy. Methods: Diabetes was induced in Balb/c mice with streptozotocin. Then, diabetic mice were divided into two groups: one group provided with BH(4) (sapropterin) in drinking water (daily doses of 15 mg/kg/day, during eight weeks) and the other that received only water. A third group of normoglycemic mice that received only water were used as the control. Results: Cardiac levels of BH(4) were increased in mice treated with BH(4) (p = 0.0019). Diabetes induced cardiac hypertrophy, which was prevented in the group that received BH(4) (p < 0.05). In addition, hypertrophy was evaluated as cardiomyocyte cross-sectional area. This was reduced in diabetic mice that received BH(4) (p = 0.0012). Diabetes induced cardiac interstitial fibrosis that was reduced in mice that received BH(4) treatment (p < 0.05). We also evaluated in the kidney the impact of BH(4) treatment on glomerular morphology. Diabetes induced glomerular hypertrophy compared with normoglycemic mice and was prevented by BH(4) treatment. In addition, diabetic mice presented glomerular fibrosis, which was prevented in mice that received BH(4). Conclusions: These results suggest that chronic treatment with BH(4) in mice ameliorates the cardiorenal effects of diabetes,(,) probably by restoring the nitroso–redox balance. This offers a possible new alternative to explore a BH(4)-based treatment for the organ damage caused by diabetes. MDPI 2022-10-04 /pmc/articles/PMC9599239/ /pubmed/36289741 http://dx.doi.org/10.3390/biomedicines10102479 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Novoa, Ulises
Soto, Karen
Valdés, Cristian
Villaseñor, Jorge
Treuer, Adriana V.
González, Daniel R.
Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis
title Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis
title_full Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis
title_fullStr Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis
title_full_unstemmed Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis
title_short Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis
title_sort tetrahydrobiopterin (bh(4)) supplementation prevents the cardiorenal effects of diabetes in mice by reducing oxidative stress, inflammation and fibrosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599239/
https://www.ncbi.nlm.nih.gov/pubmed/36289741
http://dx.doi.org/10.3390/biomedicines10102479
work_keys_str_mv AT novoaulises tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis
AT sotokaren tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis
AT valdescristian tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis
AT villasenorjorge tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis
AT treueradrianav tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis
AT gonzalezdanielr tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis